Regenerative therapies maker Bioheart (PINK:BHRT) lauded the return of president & CEO Mike Tomas who underwent emergency open-heart surgery late last year.
Tomas, 47, was up and about, making his 1st post-surgery public appearance to moderate Florida International University’s Entrepreneurs in Tech panel. Bioheart offered few other details on Tomas’ condition or the cause of surgery.
Tomas has been in the corner office and on Bioheart’s board of directors since June 2010, but has had ties to the company since the ASTRI Group, of which he is president, began investing in Bioheart in 2001.
News of Tomas’ recovery did little for Wall Street, where BHRT shares were down 4.8% today, trading at just under 2¢ apiece.
